• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个简单的 COVID-19 模型解释了疾病的严重程度和治疗效果。

A simple model of COVID-19 explains disease severity and the effect of treatments.

机构信息

T-6 Theoretical Biology and Biophysics, Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM, 87545, USA.

MPA-Q: MPA-QUANTUM, Los Alamos National Laboratory, Los Alamos, NM, 87545, USA.

出版信息

Sci Rep. 2022 Aug 20;12(1):14210. doi: 10.1038/s41598-022-18244-2.

DOI:10.1038/s41598-022-18244-2
PMID:35988008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9392071/
Abstract

Considerable effort has been made to better understand why some people suffer from severe COVID-19 while others remain asymptomatic. This has led to important clinical findings; people with severe COVID-19 generally experience persistently high levels of inflammation, slower viral load decay, display a dysregulated type-I interferon response, have less active natural killer cells and increased levels of neutrophil extracellular traps. How these findings are connected to the pathogenesis of COVID-19 remains unclear. We propose a mathematical model that sheds light on this issue by focusing on cells that trigger inflammation through molecular patterns: infected cells carrying pathogen-associated molecular patterns (PAMPs) and damaged cells producing damage-associated molecular patterns (DAMPs). The former signals the presence of pathogens while the latter signals danger such as hypoxia or lack of nutrients. Analyses show that SARS-CoV-2 infections can lead to a self-perpetuating feedback loop between DAMP expressing cells and inflammation, identifying the inability to quickly clear PAMPs and DAMPs as the main contributor to hyperinflammation. The model explains clinical findings and reveal conditions that can increase the likelihood of desired clinical outcome from treatment administration. In particular, the analysis suggest that antivirals need to be administered early during infection to have an impact on disease severity. The simplicity of the model and its high level of consistency with clinical findings motivate its use for the formulation of new treatment strategies.

摘要

人们已经付出了相当大的努力来更好地理解为什么有些人患有严重的 COVID-19,而另一些人则无症状。这导致了重要的临床发现;患有严重 COVID-19 的人通常会持续经历高水平的炎症,病毒载量下降较慢,表现出失调的 I 型干扰素反应,自然杀伤细胞活性较低,中性粒细胞胞外诱捕网水平升高。这些发现与 COVID-19 的发病机制如何相关尚不清楚。我们提出了一个数学模型,通过关注通过分子模式引发炎症的细胞来阐明这个问题:携带病原体相关分子模式(PAMPs)的感染细胞和产生损伤相关分子模式(DAMPs)的受损细胞。前者信号提示存在病原体,而后者则提示缺氧或缺乏营养等危险。分析表明,SARS-CoV-2 感染可导致 DAMPs 表达细胞与炎症之间的自我维持反馈循环,无法快速清除 PAMPs 和 DAMPs 是导致过度炎症的主要原因。该模型解释了临床发现,并揭示了可增加治疗管理后获得理想临床结果可能性的条件。特别是,分析表明抗病毒药物需要在感染早期给药,才能对疾病严重程度产生影响。该模型的简单性及其与临床发现的高度一致性促使其用于制定新的治疗策略。

相似文献

1
A simple model of COVID-19 explains disease severity and the effect of treatments.一个简单的 COVID-19 模型解释了疾病的严重程度和治疗效果。
Sci Rep. 2022 Aug 20;12(1):14210. doi: 10.1038/s41598-022-18244-2.
2
Interferon-Independent Restriction of RNA Virus Entry and Replication by a Class of Damage-Associated Molecular Patterns.一类损伤相关分子模式通过干扰素非依赖途径限制 RNA 病毒进入和复制。
mBio. 2021 Apr 13;12(2):e00584-21. doi: 10.1128/mBio.00584-21.
3
Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model.由 DAMP 为中心的免疫网络模型预测的 COVID-19 疾病轨迹分化。
Front Immunol. 2021 Oct 28;12:754127. doi: 10.3389/fimmu.2021.754127. eCollection 2021.
4
DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists.DAMPs/PAMPs 诱导 COVID-19 患者单核细胞 TLR 激活和耐受;核酸结合清除剂可以对抗这种 TLR 激动剂。
Biomaterials. 2022 Apr;283:121393. doi: 10.1016/j.biomaterials.2022.121393. Epub 2022 Jan 28.
5
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
6
COVID-19 Vaccination Limits Systemic Danger Signals in SARS-CoV-2 Infected Patients.COVID-19 疫苗接种限制 SARS-CoV-2 感染患者的全身危险信号。
Viruses. 2022 Mar 9;14(3):565. doi: 10.3390/v14030565.
7
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
8
PAMPs and DAMPs in Sepsis: A Review of Their Molecular Features and Potential Clinical Implications.脓毒症中的 PAMPs 和 DAMPs:分子特征及其潜在临床意义的综述。
Int J Mol Sci. 2024 Jan 12;25(2):962. doi: 10.3390/ijms25020962.
9
DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation.免疫与无菌性炎症中的 DAMPs、PAMPs 和 LAMPs。
Annu Rev Pathol. 2020 Jan 24;15:493-518. doi: 10.1146/annurev-pathmechdis-012419-032847. Epub 2019 Nov 1.
10
Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop.针对 SARS-CoV-2 诱导的急性肺损伤的新型治疗靶点:靶向潜在的 IL-1β/中性粒细胞胞外诱捕网反馈环。
Med Hypotheses. 2020 Oct;143:109906. doi: 10.1016/j.mehy.2020.109906. Epub 2020 May 30.

引用本文的文献

1
Viral Dynamic Models During COVID-19: Are We Ready for the Next Pandemic?新冠疫情期间的病毒动力学模型:我们是否为下一次大流行做好准备?
CPT Pharmacometrics Syst Pharmacol. 2025 Aug;14(8):1289-1297. doi: 10.1002/psp4.70055. Epub 2025 Jun 2.
2
Post-recovery viral shedding shapes wastewater-based epidemiological inferences.恢复后的病毒脱落影响基于废水的流行病学推断。
Commun Med (Lond). 2025 May 22;5(1):193. doi: 10.1038/s43856-025-00908-5.
3
The Performance of a Rapid Coronavirus Disease 2019 Antigen Test in Rural Gabon.2019年冠状病毒病快速抗原检测在加蓬农村地区的表现

本文引用的文献

1
Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms.建模再现了 SARS-CoV-2 感染的异质结果,并量化了轻症和重症患者之间固有免疫和 CD8 T 细胞反应的差异。
PLoS Pathog. 2022 Jun 27;18(6):e1010630. doi: 10.1371/journal.ppat.1010630. eCollection 2022 Jun.
2
Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load.德尔塔变异株和疫苗接种对 SARS-CoV-2 病毒载量的影响。
Viruses. 2022 Feb 4;14(2):323. doi: 10.3390/v14020323.
3
Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes.
Am J Trop Med Hyg. 2025 Feb 18;112(5):1052-1059. doi: 10.4269/ajtmh.24-0230. Print 2025 May 7.
4
A biomathematical model of SARS-CoV-2 in Syrian hamsters.叙利亚仓鼠中新冠病毒的生物数学模型。
Sci Rep. 2024 Dec 18;14(1):30541. doi: 10.1038/s41598-024-80498-9.
5
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy.一种统一的模型来解释奈玛特韦治疗后 SARS-CoV-2 频繁反弹和有限的预防效果。
Nat Commun. 2024 Jun 28;15(1):5478. doi: 10.1038/s41467-024-49458-9.
6
Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies.抗 SARS-CoV-2 抗体控制 SARS-CoV-2 感染引起的补体炎症反应。
EMBO J. 2024 Apr;43(7):1135-1163. doi: 10.1038/s44318-024-00061-0. Epub 2024 Feb 28.
7
A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound.一个统一模型,用于解释尽管奈玛特韦暴露后预防效果不佳且病毒频繁反弹,但对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)仍具有较高治疗效果。
medRxiv. 2024 Apr 17:2023.08.23.23294505. doi: 10.1101/2023.08.23.23294505.
8
COVID-19 epidemiology and rural healthcare: a survey in a Spanish village.COVID-19 流行病学与农村医疗保健:西班牙一村庄的调查。
Epidemiol Infect. 2023 Oct 27;151:e188. doi: 10.1017/S0950268823001759.
9
Multi-Omic Candidate Screening for Markers of Severe Clinical Courses of COVID-19.COVID-19严重临床病程标志物的多组学候选筛选
J Clin Med. 2023 Sep 27;12(19):6225. doi: 10.3390/jcm12196225.
10
Dynamical modelling of viral infection and cooperative immune protection in COVID-19 patients.COVID-19 患者中病毒感染和协同免疫保护的动力学建模。
PLoS Comput Biol. 2023 Sep 1;19(9):e1011383. doi: 10.1371/journal.pcbi.1011383. eCollection 2023 Sep.
纵向监测的免疫生物标志物可预测 COVID-19 结局的发生时间。
PLoS Comput Biol. 2022 Jan 18;18(1):e1009778. doi: 10.1371/journal.pcbi.1009778. eCollection 2022 Jan.
4
Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling.急性呼吸窘迫综合征(ARDS)临床试验中最小化异质性和优化策略:数学建模的见解。
EBioMedicine. 2022 Jan;75:103809. doi: 10.1016/j.ebiom.2021.103809. Epub 2022 Jan 13.
5
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.莫努匹韦片用于非住院 COVID-19 患者的口服治疗。
N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16.
6
In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.SARS-CoV-2 感染的体内动力学及其与个体传染性的关系。
Proc Natl Acad Sci U S A. 2021 Dec 7;118(49). doi: 10.1073/pnas.2111477118.
7
COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.COVID-19 虚拟患者队列提示免疫机制驱动疾病结局。
PLoS Pathog. 2021 Jul 14;17(7):e1009753. doi: 10.1371/journal.ppat.1009753. eCollection 2021 Jul.
8
Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments.宿主内 SARS-CoV-2 感染动力学建模与潜在治疗方法。
Viruses. 2021 Jun 14;13(6):1141. doi: 10.3390/v13061141.
9
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.SARS-CoV-2 的病理生理学:西奈山 COVID-19 尸检经验。
Mod Pathol. 2021 Aug;34(8):1456-1467. doi: 10.1038/s41379-021-00793-y. Epub 2021 Apr 1.
10
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.一种用于比较 SARS-CoV-2、MERS-CoV 和 SARS-CoV 宿主内动力学的定量模型,为 SARS-CoV-2 的发病机制和治疗提供了新的见解。
PLoS Biol. 2021 Mar 22;19(3):e3001128. doi: 10.1371/journal.pbio.3001128. eCollection 2021 Mar.